![](https://i.imgur.com/CLvY2jA.png")
Valneva will seek regulatory approval in the UK and European Union after its COVID-19 vaccine candidate performed well in phase 3 trials
Describing responses to the Valneva vaccine in the Cov-Compare trial as “both impressive and extremely encouraging”, chief investigator and professor of paediatrics at the University of Bristol, Adam Finn, said: “This is a much more traditional approach to vaccine manufacture… and these results suggest this vaccine candidate is on track to play an important role in overcoming the pandemic.”
The manufacturing process for VLA2001 has already been upscaled to final industrial scale.
https://www.pmlive.com/pharma_news/valne...az_1381992
Describing responses to the Valneva vaccine in the Cov-Compare trial as “both impressive and extremely encouraging”, chief investigator and professor of paediatrics at the University of Bristol, Adam Finn, said: “This is a much more traditional approach to vaccine manufacture… and these results suggest this vaccine candidate is on track to play an important role in overcoming the pandemic.”
The manufacturing process for VLA2001 has already been upscaled to final industrial scale.
https://www.pmlive.com/pharma_news/valne...az_1381992
